Business Context and Reporting Period
This Form 6-K filing by Bon Natural Life Ltd covers the month of June 2023. The company is a foreign private issuer headquartered in Xi'an, China, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events rather than financial performance.
Material Changes
- Board Resignations: Lawrence W. Leighton resigned as a member of the board of directors on June 26, 2023.
- Board Resignations: Jeffrey J. Guzy resigned as a member of the board of directors on June 28, 2023.
Outlook, Risks, and Management Commentary
Management is currently identifying and retaining new independent directors. The company intends to re-establish a majority independent board within the cure period provided by Nasdaq Rule 5605(b)(1)(A). Additionally, the company plans to reconstitute the independent audit committee and independent compensation committee within the cure periods specified by Nasdaq Rules 5605(c)(4)(B) and 5605(d)(4), respectively.
Key Facts for Investor Verification
- Verify the timeline for appointing new independent directors to ensure compliance with Nasdaq listing standards.
- Confirm the status of the independent audit and compensation committees following the resignations.
- Check for subsequent filings regarding the appointment of specific replacements for the resigned directors.